Michelle M. Cummins

1.5k total citations
31 papers, 1.2k citations indexed

About

Michelle M. Cummins is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michelle M. Cummins has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Michelle M. Cummins's work include Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (5 papers). Michelle M. Cummins is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Gastric Cancer Management and Outcomes (6 papers) and Cancer Treatment and Pharmacology (5 papers). Michelle M. Cummins collaborates with scholars based in Australia, United Kingdom and Canada. Michelle M. Cummins's co-authors include Niall C. Tebbutt, Timothy Price, Irving Dardick, Val Gebski, Martin R. Stockler, James A. Koufman, Vinod Ganju, John Zalcberg, Kate Wilson and P. David Blalock and has published in prestigious journals such as Journal of Clinical Oncology, BMJ and British Journal of Cancer.

In The Last Decade

Michelle M. Cummins

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michelle M. Cummins Australia	15	684	456	207	200	197	31	1.2k
Daniel Pietrasz France	15	740 1.1×	362 0.8×	259 1.3×	149 0.7×	289 1.5×	36	1.1k
Akiko Yokoi Japan	20	188 0.3×	567 1.2×	26 0.1×	347 1.7×	633 3.2×	80	1.2k
Wolfgang M. Brueckl Germany	21	749 1.1×	496 1.1×	58 0.3×	329 1.6×	124 0.6×	60	1.2k
Ryokuhei Manda Japan	24	422 0.6×	679 1.5×	36 0.2×	675 3.4×	690 3.5×	45	1.7k
Brent Shoji United States	8	355 0.5×	226 0.5×	91 0.4×	172 0.9×	233 1.2×	8	807
Sophie Giraud France	22	212 0.3×	429 0.9×	78 0.4×	414 2.1×	799 4.1×	45	1.9k
Ji‐Young Choe South Korea	19	699 1.0×	585 1.3×	54 0.3×	290 1.4×	194 1.0×	54	1.2k
Honsoul Kim South Korea	20	575 0.8×	186 0.4×	186 0.9×	190 0.9×	496 2.5×	59	1.5k
Danuta Perek Poland	17	249 0.4×	251 0.6×	92 0.4×	432 2.2×	167 0.8×	56	1.1k
Francesco Miccichè Italy	22	749 1.1×	392 0.9×	106 0.5×	75 0.4×	667 3.4×	56	1.4k

Countries citing papers authored by Michelle M. Cummins

Since Specialization

Citations

This map shows the geographic impact of Michelle M. Cummins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle M. Cummins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle M. Cummins more than expected).

Fields of papers citing papers by Michelle M. Cummins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle M. Cummins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle M. Cummins. The network helps show where Michelle M. Cummins may publish in the future.

Co-authorship network of co-authors of Michelle M. Cummins

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle M. Cummins. A scholar is included among the top collaborators of Michelle M. Cummins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle M. Cummins. Michelle M. Cummins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sjoquist, Katrin Marie, David Espinoza, Sonia Yip, et al.. (2024). Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial. Translational Oncology. 43. 101914–101914. 4 indexed citations

Smith, Deborah S., Kristy Robledo, Sonia Yip, et al.. (2022). Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA). Cancers. 15(1). 254–254. 1 indexed citations

Jardine, Meg, Sradha Kotwal, Abhinav Bassi, et al.. (2022). Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ. 379. e072175–e072175. 17 indexed citations

Antill, Yoland, Peey‐Sei Kok, Kristy Robledo, et al.. (2021). Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial. Journal for ImmunoTherapy of Cancer. 9(6). e002255–e002255. 80 indexed citations

Smith, Deborah S., Kristy Robledo, Sonia Yip, et al.. (2021). Tumor-associated immune cells and progression-free survival in advanced endometrial cancer (EC), results from the PHAEDRA trial (ANZGOG 1601).. Journal of Clinical Oncology. 39(15_suppl). 5584–5584.

Murphy, Felicity, Diana Zannino, Kate Wilson, et al.. (2011). Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. Annals of Oncology. 22(8). 1834–1838. 38 indexed citations

Weickhardt, Andrew, Denise Williams, John Simes, et al.. (2011). Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): Analysis of the phase III MAX study.. Journal of Clinical Oncology. 29(15_suppl). 3531–3531. 46 indexed citations

Goldstein, David, Nigel Spry, Michelle M. Cummins, et al.. (2011). The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine–oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer. British Journal of Cancer. 106(1). 61–69. 12 indexed citations

Tebbutt, Niall C., Kate Wilson, Val Gebski, et al.. (2010). Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. Journal of Clinical Oncology. 28(19). 3191–3198. 315 indexed citations

10.

Tebbutt, Niall C., Michelle M. Cummins, T. Sourjina, et al.. (2010). Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. British Journal of Cancer. 102(3). 475–481. 92 indexed citations

11.

Cummins, Michelle M., Craig Campbell, Yutaka Hosoda, et al.. (2010). Negative regulation of Ca2+ influx during P2Y2 purinergic receptor activation is mediated by Gβγ-subunits. Cell Calcium. 47(1). 55–64. 4 indexed citations

12.

Tebbutt, N. C., T. Sourjina, A. H. Strickland, et al.. (2008). ATTAX2: Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophago-gastric cancer—Final results of a multicentre phase II trial by the AGITG. Journal of Clinical Oncology. 26(15_suppl). 15554–15554. 22 indexed citations

13.

Czepulkowski, Barbara, et al.. (2005). Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes. Cancer Genetics and Cytogenetics. 156(2). 154–157. 11 indexed citations

14.

Cummins, Michelle M., et al.. (2002). Antisense co-suppression of G α q and G α 11 demonstrates that both isoforms mediate M 3 -receptor-activated Ca 2+ signalling in intact epithelial cells. Pflügers Archiv - European Journal of Physiology. 444(5). 644–653. 8 indexed citations

15.

Poronnik, Philip, et al.. (2002). Use of Adenoviruses to Study Isoform Specificity of G-Protein-Receptor-Coupled Ca<sup>2+</sup> Signaling in Intact Epithelial Cells. Cell Biochemistry and Biophysics. 36(2-3). 221–233. 1 indexed citations

16.

Cummins, Michelle M., et al.. (2000). Purinergic responses in HT29 colonic epithelial cells are mediated by G protein α -subunits. Cell Calcium. 27(5). 247–255. 11 indexed citations

17.

Dardick, Irving, et al.. (1996). Myoepithelial cells actively proliferate during atrophy of rat parotid gland. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 82(6). 674–680. 43 indexed citations

18.

Koufman, James A., David B. Averill, Michelle M. Cummins, et al.. (1996). Acid‐Induced Laryngospasm in a Canine Model. The Laryngoscope. 106(12). 1506–1509. 52 indexed citations

19.

Cummins, Michelle M., et al.. (1993). Immunohistochemical analysis of the proliterative capacity of duct and acinar cells during ligation‐induced atrophy and subsequent regeneration of rat parotid gland. Journal of Oral Pathology and Medicine. 22(10). 440–446. 55 indexed citations

20.

Cummins, Michelle M., et al.. (1993). Alternate, adjacent 2 and 3:1 meiotic segregation products from a balanced t(13;18) (q12;q11) carrier. Clinical Genetics. 44(4). 193–195. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact